Entry |
|
Name |
Ecalcidene (USAN/INN) |
Formula |
C29H45NO3
|
Exact mass |
455.3399
|
Mol weight |
455.67
|
Structure |

|
Class |
Gastrointestinal agent
DG01607 Vitamin D derivatives
|
Efficacy |
Antipsoriatic, Vitamin D receptor agonist |
Comment |
Vitamin D analog
Treatment of psoriasis
|
Target |
|
Pathway |
hsa04961 | Endocrine and other factor-regulated calcium reabsorption |
|
Interaction |
|
Brite |
Drug groups [BR:br08330]
Gastrointestinal agent
DG01607 Vitamin D derivatives
D03930 Ecalcidene
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Thyroid hormone like receptors
Vitamin D3 like receptor
NR1I1 (VDR)
D03930 Ecalcidene (USAN/INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 33
1 C1x C 23.6871 -15.5816
2 C1y C 22.2882 -15.6368
3 C1x C 21.5759 -16.7709
4 C1y C 22.2625 -17.9899
5 C2y C 23.6614 -18.0047
6 C2y C 24.3737 -16.8005
7 C2a C 24.3589 -19.2424
8 C2b C 25.7752 -16.7874
9 C2b C 26.9699 -16.0975
10 O1a O 21.5391 -19.2126
11 O1a O 21.6015 -14.3480
12 C2y C 26.9701 -14.6890
13 C1y C 28.1606 -14.0015
14 C1z C 28.1605 -12.6025
15 C1x C 26.9489 -11.9031
16 C1x C 25.7584 -12.5905
17 C1x C 25.7585 -13.9896
18 C1x C 29.4912 -14.4337
19 C1x C 30.3135 -13.3019
20 C1y C 29.4911 -12.1701
21 C1a C 28.1605 -11.2035
22 C1c C 29.4966 -10.7754
23 C1b C 30.7396 -10.0689
24 C1a C 28.3023 -10.0747
25 C1b C 31.9701 -10.7909
26 C5a C 33.1741 -10.1069
27 N1y N 34.4022 -10.8279
28 O5a O 33.1840 -8.7059
29 C1x C 34.3921 -12.2290
30 C1x C 35.5986 -12.9372
31 C1x C 36.8152 -12.2464
32 C1x C 36.8253 -10.8454
33 C1x C 35.6187 -10.1372
BOND 36
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 5 6 1
6 1 6 1
7 5 7 2
8 6 8 2
9 8 9 1
10 4 10 1 #Up
11 2 11 1 #Down
12 9 12 2
13 12 13 1
14 13 14 1
15 14 15 1
16 15 16 1
17 16 17 1
18 12 17 1
19 13 18 1
20 18 19 1
21 19 20 1
22 14 20 1
23 14 21 1 #Up
24 20 22 1
25 22 23 1
26 22 24 1 #Up
27 23 25 1
28 25 26 1
29 26 27 1
30 26 28 2
31 27 29 1
32 29 30 1
33 30 31 1
34 31 32 1
35 32 33 1
36 27 33 1
|